{'52WeekChange': -0.11290324,
 'SandP52WeekChange': None,
 'address1': 'One Azrieli Center',
 'address2': '19th Floor Round Tower 132 Menachem Begin Road',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 0.7689,
 'askSize': 3000,
 'averageDailyVolume10Day': 10790137,
 'averageVolume': 33324061,
 'averageVolume10days': 10790137,
 'beta': 2.571978,
 'beta3Year': None,
 'bid': 0.76,
 'bidSize': 1300,
 'bookValue': 0.533,
 'category': None,
 'circulatingSupply': None,
 'city': 'Tel Aviv',
 'companyOfficers': [],
 'country': 'Israel',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 0.78,
 'dayLow': 0.72,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -3.919,
 'enterpriseToRevenue': 26.608,
 'enterpriseValue': 26607690,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '972 3 509 7196',
 'fiftyDayAverage': 0.75254285,
 'fiftyTwoWeekHigh': 1.44,
 'fiftyTwoWeekLow': 0.22,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 33468098,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 9,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.04671,
 'heldPercentInstitutions': 0.28188,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/kitovpharma.com',
 'longBusinessSummary': 'Kitov Pharma Ltd, through its subsidiaries, operates '
                        'as a development stage biopharmaceutical company in '
                        'Israel. The company operates through two segments, '
                        'Pain and Hypertension; and Oncology. It develops '
                        'combination drugs for the simultaneous treatment of '
                        'pain caused by osteoarthritis and hypertension. The '
                        "company's lead drug candidate is Consensi a "
                        'combination of APIs celecoxib and amlodipine '
                        'besylate. It is also developing NT219, a small '
                        'molecule that targets two oncology-related proteins '
                        'to overcome resistance to cancer drug treatment. The '
                        'company was formerly known as Kitov Pharmaceuticals '
                        'Holdings Ltd. and changed its name to Kitov Pharma '
                        'Ltd in January 2018. Kitov Pharma Ltd was founded in '
                        '2010 and is headquartered in Tel Aviv, Israel.',
 'longName': 'Kitov Pharma Ltd',
 'market': 'us_market',
 'marketCap': 121260744,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_20357677',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1577750400,
 'navPrice': None,
 'netIncomeToCommon': -5850000,
 'nextFiscalYearEnd': 1640908800,
 'open': 0.7639,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '972 3 933 3121',
 'previousClose': 0.77,
 'priceHint': 4,
 'priceToBook': 1.4071295,
 'priceToSalesTrailing12Months': 121.26074,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 0.78,
 'regularMarketDayLow': 0.72,
 'regularMarketOpen': 0.7639,
 'regularMarketPreviousClose': 0.77,
 'regularMarketPrice': 0.7639,
 'regularMarketVolume': 6005940,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 158039008,
 'sharesPercentSharesOut': 0.0414,
 'sharesShort': 4758301,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 6745692,
 'shortName': 'Kitov Pharma Ltd.',
 'shortPercentOfFloat': None,
 'shortRatio': 0.13,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'KTOV',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.302,
 'twoHundredDayAverage': 0.5784029,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '842b9c84-2d83-3c70-b580-d74a65583fe7',
 'volume': 6005940,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.kitovpharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '6701101'}